A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant
- PMID: 37279971
- DOI: 10.1001/jama.2023.9100
A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant
Comment on
-
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.JAMA. 2023 Jul 3;330(1):33-42. doi: 10.1001/jama.2023.9106. JAMA. 2023. PMID: 37279999 Free PMC article.
